Treatment of Sheehan Syndrome in Central Adrenal Insufficiency Due to ACTH Deficiency

Clinical Scenario

This protocol covers Sheehan syndrome occurring in the context of central adrenal insufficiency due to ACTH deficiency — a state in which inadequate cortisol secretion arises from insufficient pituitary ACTH output rather than from primary adrenal failure.

Condition

Central adrenal insufficiency represents inadequate cortisol secretion due to ACTH deficiency. Because the deficit originates at the pituitary level, treatment must address the downstream cortisol gap with appropriate replacement.

Treatment Approach

The cornerstone of management is glucocorticoid replacement with hydrocortisone (HC), individually tailored to the patient. The complete protocol specifies the recommended dosing strategy, scheduling approach, and the criteria under which alternative longer-acting glucocorticoids may be considered instead.

Full regimen details — including dose, schedule structure, and agent selection criteria — are available in the structured protocol below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1210/jc.2016-2118

Central AI represents inadequate cortisol secretion due to ACTH deficiency.

We recommend using HC, usually 15–20 mg total daily dose in single or divided doses.

Patients using divided doses should take the highest dose in the morning at awakening and the second in the afternoon (two-dose regime) or the second and third at lunch and late afternoon, respectively (three-dose regime).

We suggest using longer-acting GCs in selected cases (eg, nonavailability, poor compliance, convenience).

View source ↗